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Outer diameter measured by 3D CISS MRI and quasi-
Moyamoya disease
The interesting article by Kaku Y et al.: Outer diameter
narrowing of the internal carotid artery and the middle
cerebral arteries detected in Moyamoya disease detected
on 3D constructive interference in steady-state (CISS) MR
image…, shows us once more that:
1. The pathology of Moyamoya disease, especially its
pathological vessel walls, compared with those of other
cerebrovascular diseases like atherosclerosis.
One has to observe not only changes of the inner
diameter of the pathological vessels but also that of the
outer diameter caused by remodeling of vascular wall
originating in the pathological process of a disease. Until
now, we have paid attention only to the inner diameter,
namely luminal stenosis or occlusion on the basis of
angiographical or MRI findings. The 3D-CISS MRI has
been revealed to be a good tool for measurement of the
outer diameter to observe the latter process for instance
changes of vascular wall thickness due to its remodeling.
2. The definition of Moyamoya disease and its differenti-
ation from related diseases.
The terminology Quasi-Moyamoya disease (<rui>
Moyamoya disease in Japanese) could be found, so far
as the author has searched around, initially in a chapter
of the book Moyamoya disease edited by Prof. J Suzuki
(one of finders of this disease and has coined the name
of “Moyamoya”) in 1983 [3]. Watanabe T and Suzuki N
classified as “rui” Moyamoya disease which was how-
ever out of diagnostic criteria of Moyamoya disease,
including:
a. Only one side corresponds with the criteria of Moya-
moya disease (1) but the other side having normal
vasculatures.
b. Cases with one side or bilateral middle cerebral artery
MCA stenosis at the origin associated with Moyamoya
vessels, however, combined with neither internal carotid
artery ICA nor anterior cerebral artery ACA stenoses
c. Combination with congenital malformation: AVM,
primitive trigeminal artery
d. Associated with apparent basic disease such as: von
Recklinghausen disease, head trauma (mechanical vaso-
constriction), fibromuscular dysplasia, tuberculous men-
ingitis, atherosclerosis, post-irradiation, Fanconi’s
anemia, sickle cell anemia, nonspecific arteritis, connec-
tive tissue anomaly, cerebral angiitis due to leptospirosis
As you can follow, the definition of “rui” Moyamoya dis-
ease thus inherits some confusion, while the definition of the
research committee under the guideline (bilaterality of findings
of seno-occlusion at the terminal portion of the ICA and at
proximal portion of the MCA and ACA combined with abnor-
mal vasculatures Moyamoya at basal portion of the brain, and
without any basic disease [1]) originally set in 1979 was far
more clear in separating Moyamoya disease from Moyamoya
syndrome having basic disease [1]. The name “rui” seems to
have changed into “quasi” at the time of the English edition of
the above-mentioned book in 1986 published by Springer.
The author of this editorial did not know, however,
until quite recently that the research committee has now
included the terminology quasi-Moyamoya disease into
the diagnostic guideline in 2012 (originally in 2009 in
Japanese) [2], so that this terminology can be used
equally to Moyamoya syndrome, which means that
quasi-Moyamoya disease also includes atherosclerosis
but excludes unilateral pathology without basic disease
(above mentioned in “a”) namely probable Moyamoya
disease, and quasi-Moyamoya disease also includes the
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one with hyperthyroidism as shown in Fig. 1 and at-
tached legends. The guideline excludes, by the way,
AVMs, aneurysms, or congenital vascular anomalies
such as primitive trigeminal artery as “basic” disease,
what was still not the case at that time in the above-
mentioned original paper of “rui” Moyamoya disease, as
can be seen in “c”. Differentiation of “basic disease or
underlying disease” from “concomitant or associated
disease” is not always easy. After all, terminology of
quasi-Moyamoya disease is considered still not to be
free of confusion and not to have obtained general
acceptance.
The original manuscript by Kaku et al. did not in-
clude any mention of quasi-Moyamoya disease, so that
it was rather clear cut in differentiating findings of 3D
CISS between Moyamoya disease and atherosclerotic
cerebrovascular disease. Readers are, therefore, asked
not to be confused with the final version, mentioning
additionally about hyperthyroidism, whose combination
belongs also to quasi-Moyamoya disease or Moyamoya
syndrome, which includes also atherosclerosis as basic
disease.
By the way, we also use from time to time the
terminology Moyamoya angiopathy MMA [4, 5], in
which all the clinico-pathology of Moyamoya disease,
Moyamoya syndrome, and unilateral pathology are in-
cluded. This concept has originated from the idea that
the management–treatment of ischemia, epilepsy, or
bleeding due to this entity can be performed on the
base of similar clinico-pathophysiology and not neces-
sarily based on the etiology.
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